Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Schmer

Showing results (11-20 of 70) with videos related to

Pageof 7
Sort By:
British Journal of Haematology|October 1, 1975
A simple two-step isolation procedure for human and bovine antithrombin II/III (heparin cofactor): a comparison of two methodsE Thaler, G Schmer
British Journal of Haematology|May 1, 1975
A solid-phase radioassay for the quantitative determination of antiplasmin activity in human plasmaG Schmer, H E Branson
Thrombosis Research|January 1, 1985
Fibrinogen Seattle II: defective release of fibrinopeptide A in a slow clotting fibrinogenW E Schreiber, G Schmer
Clinical Chemistry|March 1, 1986
Evaluation of a new dynamic viscometer for measuring the viscosity of whole blood and plasmaW L Chandler, G Schmer
Methods in Enzymology|January 1, 1988
Enzyme reactors for the removal of amino acids from plasmaG Schmer, W L Chandler
Journal of Neurosurgery|January 1, 1981
A method for monitoring antifibrinolytic therapy in patients with ruptured intracranial aneurysmsK J Burchiel, G Schmer
The Journal of Laboratory and Clinical Medicine|October 1, 1984
Application of mechanical impedance measurements to the study of dysfibrinogensW E Schreiber, G Schmer
The Journal of Biological Chemistry|September 25, 1977
Isolation, crystallization, and primary amino acid sequence of human platelet factor 4M Hermodson, G Schmer, K Kurachi
Circulation|January 1, 1989
Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1)P Angleton, W L Chandler, G Schmer
Biochemical and Biophysical Research Communications|November 29, 1978
Heparin binding to antithrombin III: variation in binding sites and affinityM W Piepkorn, D Lagunoff, G Schmer
Pageof 7

Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
British Journal of Haematology|October 1, 1975
A simple two-step isolation procedure for human and bovine antithrombin II/III (heparin cofactor): a comparison of two methodsE Thaler, G Schmer
British Journal of Haematology|May 1, 1975
A solid-phase radioassay for the quantitative determination of antiplasmin activity in human plasmaG Schmer, H E Branson
Thrombosis Research|January 1, 1985
Fibrinogen Seattle II: defective release of fibrinopeptide A in a slow clotting fibrinogenW E Schreiber, G Schmer
Clinical Chemistry|March 1, 1986
Evaluation of a new dynamic viscometer for measuring the viscosity of whole blood and plasmaW L Chandler, G Schmer
Methods in Enzymology|January 1, 1988
Enzyme reactors for the removal of amino acids from plasmaG Schmer, W L Chandler
Journal of Neurosurgery|January 1, 1981
A method for monitoring antifibrinolytic therapy in patients with ruptured intracranial aneurysmsK J Burchiel, G Schmer
The Journal of Laboratory and Clinical Medicine|October 1, 1984
Application of mechanical impedance measurements to the study of dysfibrinogensW E Schreiber, G Schmer
The Journal of Biological Chemistry|September 25, 1977
Isolation, crystallization, and primary amino acid sequence of human platelet factor 4M Hermodson, G Schmer, K Kurachi
Circulation|January 1, 1989
Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1)P Angleton, W L Chandler, G Schmer
Biochemical and Biophysical Research Communications|November 29, 1978
Heparin binding to antithrombin III: variation in binding sites and affinityM W Piepkorn, D Lagunoff, G Schmer
Pageof 7